Literature DB >> 23010402

[Eosinophilic angiocentric fibrosis: a form of IgG4-related systemic disease?].

Amal Benlemlih1, Vanessa Szableski, Mouhcine Bendahou, Sophie Rivière, Max Villain, Valérie Costes.   

Abstract

Eosinophilic angiocentric fibrosis is a rare fibro-inflammatory disorder of unknown etiology with only 40 cases reported in the literature. It primarily affects the sinonasal tract and more rarely the orbit, the larynx and the gums. This benign disorder is characterized by a slowly progressive process mimicking a tumor, with frequent recurrences after surgical excision and cortico-therapy. The typical histology consists of fibro-inflammatory lesion with numerous eosinophils, arranged in a perivascular pattern. As the lesion matures, inflammation becomes less intense and the fibrosis progresses with an onion-skin type perivascular fibrosis. A recent paper suggests that EAF is part of the spectrum of IgG4-related systemic disease. We report a case of orbital EAF in an 86-year-old woman which sustained this hypothesis.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23010402     DOI: 10.1016/j.annpat.2012.06.008

Source DB:  PubMed          Journal:  Ann Pathol        ISSN: 0242-6498            Impact factor:   0.407


  3 in total

1.  Nasal Eosinophilic Angiocentric Fibrosis with Orbital Extension.

Authors:  Mohammad Faramarzi; Mohammad Hossein Dadgarnia; Mansour Moghimi; Hadi Sharouny; Nasim Behniafard
Journal:  Head Neck Pathol       Date:  2015-01-20

2.  Eosinophilic Angiocentric Fibrosis of the Nasal Cavities: A Report of an Uncommon Lesion with Emphasis on the Etiology and Differential Diagnosis.

Authors:  Jessica Farina; Giuseppe Broggi; Carmelo Federico; Magda Zanelli; Andrea Palicelli; Rosario Caltabiano
Journal:  Medicina (Kaunas)       Date:  2022-06-28       Impact factor: 2.948

Review 3.  Eosinophilic angiocentric fibrosis of the sinonasal tract: a case report and review of the literature.

Authors:  Etrat Javadirad; Narges Eskandari Roozbahani; Sepehr Sadafi
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.